CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Anat Cohen-Dayag

Executive Chair, Compugen

Search every verified Anat Cohen-Dayag interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Dr. Anat Cohen-Dayag, Executive Chair at Compugen, discussed the company's transformation from a computational biology service provider into a clinical-stage biopharmaceutical company focused on cancer immunotherapy. In a 2021 interview, she described how the company leveraged its status as a public company, using different financial instruments to fund its pipeline before having sufficient early-stage data to pursue public offerings. She noted that Compugen entered into a collaboration with Bayer, licensing to them the rights to develop drugs for one of the targets the company identified. Cohen-Dayag also outlined Compugen's strategy, which includes advancing its clinical-stage pipeline, developing early-stage programs to feed that pipeline, and using its computational engine to sustain its own discoveries. She stated that after presenting clinical data and establishing collaborations with Bristol-Myers Squibb, AstraZeneca, and Bayer, the company conducted another round of offering.

Recent appearances

  • Episode 4 - Dr. Anat Cohen-Dayag, Executive Chairperson @ former CEO, Compugen ltd.

    September 13, 2026 · 📺 Non-Sterile לא סטרילי

    In the fourth episode of "Non-Sterile", we host Dr. Anat Cohen-Dayag, Executive Chairperson and former CEO of Compugen. Dr. Cohen-Dayag shares her personal journey from academia to industry and reveals how she led the company’s transformation from a computational biology service provider on the brink of crisis into a global oncology drug discovery company. The conversation goes behind the scenes of forging strategic partnerships with pharma giants, the challenges of managing a dual-based company integrating Israeli and American scientists, and the importance of advancing women and mentorshi…

    Watch on YouTube ↗

  • A Biopharma Pivot Story With Compugen's Dr. Anat Cohen-Dayag

    March 15, 2021 · 📺 Life Science Connect

    Dr. Anat Cohen-Dayag transformed her company from a computational biology service provider to a clinical-stage biopharma with multiple cancer immunotherapy candidates, and she did it in a remarkably short period of time. Listen in as she discusses the human resources, financial, and capital strategies she deployed to build a biotech on the back of computational science, and shares her vision for the future of drug discovery. #businessofbiotech #biopharma #biotech #cytiva http://cytiva.com/emergingbiotech Audio version available here: https://www.bioprocessonline.com/doc/... Subscribe to th…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →